Clinical Trial Update: Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease [NA]

View source ↗

Summary

A clinical trial is investigating dietary glycine supplementation for metabolic dysfunction-associated fatty liver disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease

Drugs mentioned

• Glycine (glycine)

Snippet

Sponsor: Singapore General Hospital | Conditions: Metabolic Dysfunction Associated Fatty Liver Disease | NA | Status: NOT_YET_RECRUITING